Hot Features
プレミアム
Addex Therapeutics Ltd (0QNV)
LSE
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update Indivior selected GABA B PAM drug candidate for development in substance use disorders (SUD) and starts IND...
Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024 Nine-month Results Remain On Track for Net Profit Ad Hoc Announcement Pursuant to Art. 53 LR Geneva...
Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update Launched Neurosterix with Perceptive Advisors to accelerate the development of M4PAM...
Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 19, 2024 - Addex...
Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Geneva, Switzerland, September 4, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage...
Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, August 27, 2024...
Addex’s Partner Discontinues ADX71149 development in Epilepsy Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a...
Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS) Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland...
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...
Addex Shareholders Approve All Resolutions at Annual General Meeting Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 1, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq:...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 3.02 | 3.02 | 3.02 | 0 | 0 | DE |
| 4 | 0 | 0 | 3.02 | 3.02 | 3.02 | 0 | 0 | DE |
| 12 | 0 | 0 | 3.02 | 3.02 | 3.02 | 0 | 0 | DE |
| 26 | 0 | 0 | 3.02 | 3.02 | 3.02 | 539 | 3.02 | DE |
| 52 | 0 | 0 | 3.02 | 3.02 | 3.02 | 1462 | 3.02 | DE |
| 156 | 0 | 0 | 3.02 | 3.02 | 3.02 | 904 | 3.02 | DE |
| 260 | 0 | 0 | 3.02 | 3.02 | 3.02 | 775 | 3.02 | DE |
Stumblebum
3分前
Slim6
3分前
kenjiroo
3分前
BigBadWolf
4分前
weedtrader420
4分前
Golden Cross
4分前
GrantHorvat1
4分前
Checkmate 36
4分前
1vman
4分前
richme
4分前
Green Leaf Smoker
4分前
DCBill
4分前
Lone Clone
4分前
art2426
5分前
branster
5分前
Whalatane
5分前
dexprs
6分前
Klinsmann
6分前
Risk vs Reward
6分前
TightCoil
7分前
ETG58
7分前
John Doe 2024
7分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
